Organigram is Canada's largest licensed cannabis producer by market share, growing and selling cannabis and cannabis-derived products to adult recreational and medical consumers. Core products include dried flower, pre-rolls, vapes, gummies, hash, and concentrates, sold under brands including SHRED, BOXHOT, Big Bag O' Buds, Edison, and Tremblant. Organigram sells domestically through provincial government wholesale channels, with no direct retail presence, and exports bulk dried flower and derivatives to medical markets in Germany, Australia, and the U.K. The company operates a single production facility in Moncton, New Brunswick, with specialized processing across several Canadian sites. Organigram holds the #1 national position in vapes, pre-rolls, hash, milled flower, and concentrates, and roughly 11-12% total national market share. Key profit drivers include scale-driven cost efficiency, product mix toward higher-margin derivatives, and international exports — which carry structurally higher margins since they are not subject to Canada's per-gram excise tax. Organigram also runs a B2B tolling and white-label division that monetizes spare processing capacity. British American Tobacco holds roughly 30% of common shares and jointly operates a Centre of Excellence with Organigram focused on product innovation; the FAST nanoemulsion technology — which delivers faster onset and higher cannabinoid absorption in edibles — is the first commercialized output of this partnership. Growth priorities include international expansion, pending EU-GMP certification, and a nascent U.S. hemp-derived THC beverage business entered via the April 2025 acquisition of Collective Project.